• In August 2022, SourceMark Medical announced that it was awarded a group purchasing agreement with Premier, Inc. for its Tourniquet Touch Pneumatic Tourniquet system.

• In October 2018, Zimmer Biomet partnered with Apple to launch a major clinical research initiative aimed at improving patient experiences and advancing the journey of joint replacement. This collaboration focused on gathering detailed insights from patients to enhance joint replacement outcomes.

In this report, the Tourniquet Market has been segmented by Product Type, Application, End Users and Geography.

Tourniquet Market , Segmentation by Product Type

The Tourniquet Market has been segmented by Product Type into Tourniquet Systems and Tourniquet Cuffs.

Tourniquet Systems

Tourniquet Systems, including electronic and pneumatic devices, are designed to precisely control limb occlusion pressure during surgical procedures. These systems account for approximately 40% of the global tourniquet market as of 2025. Their growing adoption is largely driven by the increasing volume of orthopedic surgeries and the need for advanced technology in modern operating rooms. Leading manufacturers such as Zimmer Biomet and Stryker continue to innovate in this space, offering systems that improve surgical efficiency and patient outcomes.

Tourniquet Cuffs

Tourniquet Cuffs—available in reusable and disposable formats—are essential components used to temporarily restrict blood flow during medical procedures. In 2025, they represent about 35% of the global market. Their popularity stems from affordability, ease of use, and compatibility with a wide range of tourniquet systems. These features make them particularly effective in outpatient settings and facilities with strict infection control requirements. Key players like Ulrich Medical and VBM Medizintechnik GmbH are known for producing high-quality cuffs designed for safety and comfort.

Tourniquet Market , Segmentation by Application

The Tourniquet Market has been segmented by Application into Lower-Limb Surgery, and Upper-Limb Surgery.

Lower-Limb Surgery

Lower-limb surgical procedures, such as knee arthroplasty and hip replacements, constitute a significant portion of the tourniquet market. These procedures often require blood flow control to ensure a clear surgical field, making tourniquets essential. The increasing prevalence of osteoarthritis and an aging population contribute to the growing demand for lower-limb surgeries. Consequently, this segment holds a substantial share of the market, reflecting its critical role in orthopedic interventions.

Upper-Limb Surgery

Upper-limb surgeries, including procedures on the arm and hand, utilize tourniquets to manage blood loss and enhance surgical precision. While this segment represents a smaller portion of the market compared to lower-limb surgeries, it is experiencing steady growth. Advancements in minimally invasive techniques and the rising number of elective upper-limb procedures contribute to this upward trend. The demand for upper-limb surgical interventions continues to expand, underscoring its importance within the tourniquet market.

Tourniquet Market , Segmentation by End Users

The Tourniquet Market has been segmented by End Users into Hospitals, Physician/Clinic, and Non-Institutional.

Hospitals

Hospitals are the primary end users of tourniquet systems, accounting for approximately 46.0% of the market share in 2023. This dominance is attributed to the high volume of orthopedic surgeries and trauma cases managed in hospital settings, where tourniquets are essential for blood flow control during procedures. The presence of advanced healthcare infrastructure and trained medical professionals further supports the extensive use of tourniquet devices in hospitals.

Physician/Clinics

Physician offices and clinics represent a significant segment in the tourniquet market, driven by the increasing number of outpatient procedures and minor surgeries performed in these settings. The demand for portable and user-friendly tourniquet systems is rising, as they facilitate efficient blood management during various medical interventions. Clinics focusing on orthopedic and vascular treatments particularly benefit from incorporating tourniquet devices into their practice.

Non-Institutional

The non-institutional segment, including emergency responders, military personnel, and individual users, is experiencing notable growth in the tourniquet market. This expansion is fueled by increased awareness of emergency bleeding control and the availability of compact and cost-effective tourniquet solutions. The adoption of tourniquets in first aid kits and personal emergency equipment underscores their critical role in pre-hospital care and disaster response scenarios.

Tourniquet Market, Segmentation by Geography

In this report, the Tourniquet Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Tourniquet Market Share (%), by Geographical Region

North America

North America continues to lead the global tourniquet market, holding around 53.4% of the total market share as of 2023. This dominance is supported by the region’s well-established healthcare infrastructure, widespread use of advanced medical technologies, and a high volume of orthopedic surgical procedures. The United States is the primary contributor, driven by an aging population and a strong network of specialized healthcare professionals.

Europe

Europe remains a key region in the tourniquet market, bolstered by an aging population and the growing demand for orthopedic treatments. While it ranks behind North America in size, the region benefits from high standards in patient safety and strong adoption of precision-driven surgical tools. Countries such as Germany and the UK are central to market growth, supported by a skilled medical workforce and leading device manufacturers.

Asia Pacific

Asia Pacific is expected to witness the fastest expansion in the tourniquet market, backed by rising healthcare investments and an increase in trauma-related procedures. Nations like China, India, and Indonesia are experiencing a surge in demand due to larger populations, more frequent road traffic accidents, and a focus on expanding local manufacturing capabilities. This region represents a major growth opportunity for industry stakeholders.

Middle East and Africa

The Middle East and Africa region is gradually gaining traction in the global tourniquet market, thanks to improvements in healthcare infrastructure and better access to emergency medical equipment. Countries within the GCC and South Africa are at the forefront, with growing government investments and training initiatives aimed at enhancing pre-hospital care and trauma readiness.

Latin America

Latin America is emerging as a promising market for tourniquets, supported by the expansion of public and private healthcare systems. Brazil and Mexico are among the fastest-growing contributors, driven by a rising need for trauma management solutions and improvements in emergency care infrastructure. The region is increasingly focused on adopting tourniquets for both surgical and pre-hospital emergency use.

This report provides an in depth analysis of various factors that impact the dynamics of Tourniquet Market. These factors include; Market Drivers, Restraints and Opportunities Analysis,

Drivers, Restraints and Opportunity Analysis

Drivers

• Rising number of surgical procedures globally
• Advancements in pneumatic and automatic tourniquets

• Growing focus on blood loss management - The increasing emphasis on managing blood loss effectively during surgeries and emergencies is fueling demand for tourniquets. These devices are essential for temporarily restricting blood flow to limbs, which helps minimize bleeding and creates a clearer surgical field. This control reduces the need for blood transfusions, thereby lowering associated risks and healthcare costs.

  Medical facilities are adopting comprehensive blood conservation strategies where timely hemorrhage control is prioritized. Tourniquets have become critical tools in procedures such as orthopedic, vascular, and reconstructive surgeries, as well as in trauma care, improving patient safety and surgical outcomes.

  Recent advancements in tourniquet technology, including precise pressure regulation and real-time monitoring, align with the need for accurate blood management. These innovations ensure optimal pressure application, reducing tissue damage while effectively controlling bleeding.

  As healthcare systems worldwide strive for improved surgical safety and complication reduction, the role of tourniquets in blood loss management is set to expand. This growing focus supports increasing demand for reliable tourniquet solutions in both surgical and emergency care environments.

Restraints

• Lack of standardized usage guidelines
• High cost of advanced tourniquet devices

• Limited awareness in developing healthcare regions - Lack of awareness and training on proper tourniquet use in developing healthcare regions significantly limits market growth. Healthcare providers in low-resource settings often lack access to education about the benefits and correct application of tourniquets, leading to underuse and suboptimal patient outcomes.

  The absence of widely disseminated guidelines and training exacerbates this issue. Improper usage risks such as nerve damage, ischemia, or ineffective hemorrhage control reduce confidence in these devices, particularly where trauma care is critical.

  Economic constraints further restrict access to modern tourniquet technologies in underserved areas. Many facilities rely on outdated or makeshift methods, which may be less effective and riskier for patients. This combination of cost and awareness barriers limits adoption where demand is high.

  Addressing these challenges requires targeted education, training programs, and improved access to affordable tourniquet devices. Enhancing knowledge and skills among healthcare workers will be vital for market expansion and improving trauma care outcomes in these regions.

Opportunities

• Expansion in military and pre-hospital applications
• Rising investments in trauma care technologies

• Adoption of tourniquets in minimally invasive surgeries - The rise of minimally invasive surgeries presents a promising opportunity for the tourniquet market. These procedures demand precise blood flow control to maintain clear visibility and reduce bleeding. Tourniquets offer an effective means to achieve this, enabling surgeons to perform with greater accuracy and safety.

  With minimally invasive techniques gaining popularity due to benefits like smaller incisions and faster recovery, demand for compatible tourniquets is increasing. Innovations such as precise pressure control and ergonomic designs improve their suitability for delicate surgical environments.

  Integration with digital monitoring and enhanced safety features minimizes risks associated with tourniquet use, making them more appealing in high-precision surgical settings. The growth of outpatient and ambulatory surgeries further drives demand for reliable, easy-to-use blood control devices.

  As surgical innovation continues to prioritize less invasive methods globally, manufacturers developing tourniquets tailored to these needs stand to capture growing market share. This trend offers substantial growth potential in both established and emerging healthcare markets.

Key players in Tourniquet Market include;

• Delfi Medical Innovation, Inc.
• Hammarplast Medical AB
• Pyng Medical Corporation
• Stryker Corporation
• Ulrich Medical
• VBM Medizintechnik GmbH
• Zimmer Biomet Holdings

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Market Share Analysis
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis